1. India Stocks

  2. •

    Technology

  3. •

    Information Technology Services
Zensar Technologies Limited

Zensar Technologies Limited

ZENSARTECH.NS
Zensar Technologies LimitedIN flagNational Stock Exchange of India
467.70
INR
-10.25
- -
106.05BMarket Cap
Zensar Technologies Limited
ZENSARTECH.NS
(National Stock Exchange of India)

Recent

price

467.70

P/E

ratio

- -

div

yld

- -

ROIC.AI

2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
TTM
FRC
53.35
82.16
97.21
106.07
119.66
132.17
136.6
138.33
176.23
185.63
167.72
187.88
214.18
216.41
232.82
250.52
237.01
Revenue per Share
6.09
7.32
8.02
10.88
12.05
13.03
10.5
10.75
13.93
11.69
13.31
18.43
14.47
29.36
28.65
34.12
29.7
Basic EPS, GAAP
5.24
6.77
3.33
8.07
12.9
9.54
12.03
6.83
4.6
26.99
36.3
12.35
29.93
27.62
23.28
31.59
- -
Free Cash Flow per Basic Share
0.64
1.52
1.74
1.88
2.47
4.36
1.17
2.79
2.81
5.32
1.2
3.9
5
5.5
9
13.4
- -
Dividend per Share
20.64
12.33
13.86
17.88
19.03
21.12
25.57
29.16
34.36
40.17
52.18
64.74
75.75
99.34
120.62
2
- -
Book Value per Share
9.23
13.52
19.69
28.04
34.09
43.85
50.05
52.86
49.13
54.93
72.15
80.31
94.05
121.48
136.14
153.87
- -
Tangible Book Value per Share
216
217
218
218
220
222
224
225
225
225
225
226
226
227
227
227
227
Basic Weighted Avg Shares
11,531
17,825
21,145
23,156
26,277
29,381
30,556
31,077
39,663
41,817
37,814
42,438
48,482
49,019
52,806
56,874
53,775
Sales/Revenue/Turnover
13.35
12.29
12.83
14.29
13.56
12.8
10.99
10.14
10.73
10.04
15.3
12.41
7.64
15.31
13.54
14.5
13.59
Operating Margin (%)
289
333
332
383
415
651
486
651
894
1,592
1,747
1,848
1,830
1,338
1,019
913
1,003
Depreciation Expense
1,317
1,587
1,745
2,375
2,646
2,896
2,349
2,415
3,136
2,634
3,000
4,163
3,276
6,650
6,498
7,746
6,739
Net Income, GAAP
20.25
32.86
33.03
30.11
27.68
29.88
31.62
29.89
28.45
27.73
29.08
26.55
26.23
24.07
24.24
24.19
24.16
Effective Tax Rate (%)
11.42
8.9
8.25
10.26
10.07
9.86
7.69
7.77
7.91
6.3
7.93
9.81
6.76
13.57
12.31
13.62
12.53
Profit Margin (%)
2,585
3,517
4,452
5,721
6,155
8,356
8,869
9,332
9,875
10,182
12,544
14,353
14,602
17,401
24,324
29,003
- -
Working Capital
2,140
1,859
1,335
746
15
8
3
60
1,022
3,783
2,539
2,348
1,904
1,228
783
442
- -
LT Debt
4,460
5,759
7,289
9,466
10,554
12,690
14,790
16,826
19,593
21,137
23,711
26,869
29,762
35,619
40,697
47,191
- -
Total Equity
23.74
19.9
20.84
22.87
22.21
20.07
15.19
13.59
15.91
12.09
14.82
13.47
8.67
16.17
13.55
13.8
- -
Return on Invested Capital (%)
26.06
27.21
34.9
44.78
45.92
47.56
34.93
35.63
37.27
21.13
19.98
26.03
18.32
30.72
25.03
52.5
295.71
Return on Capital (%)
33.96
44.49
61.35
68.66
65.48
65.26
45.11
39.37
43.9
31.39
28.83
31.55
20.62
33.55
26.06
55.7
- -
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
Dec'25
Mar'25
Jun'26
ST Debt
- -
469
- -
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
783
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
- -
227
- -
Market Capitalization
170,415
158,951
191,162

Working Capital

FRC

•

in mil. unless spec.
Dec'25
Mar'25
Jun'26
Total Current Assets
- -
33,146
- -
Cash, Cash Equivalents & STI
- -
19,987
- -
Accounts Receivable, Net
- -
7,901
- -
Inventories
- -
- -
- -
Total Current Liabilities
- -
8,822
- -
Payables & Accruals
- -
- -
- -
ST Debt
- -
469
- -
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
14.08%
14.8%
15.96%
Free Cash Flow
56.25%
17.91%
35.79%
Net Income, GAAP
14.9%
27.47%
19.21%
Sales/Revenue/Turnover
7.22%
8.6%
7.7%
Total Cash Common Dividend
45.62%
75.31%
49.09%

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
12,272
12,408
12,041
12,297
49,019
2025
12,881
13,080
13,256
13,589
52,806
2026
13,850
14,307
14,504
- -
56,874

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
6.9
7.68
7.14
- -
29.36
2025
6.96
6.88
7.04
7.77
28.65
2026
8.01
8.8
9.29
- -
34.12

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
5.5
2025
- -
- -
- -
- -
9
2026
- -
- -
- -
- -
13.4
Similar Companies
YE DIGITAL Corporation (2354.T)
Power Solutions, Ltd. (4450.T)
Allied Digital Services Limited (ADSL.BO)
PharmX Technologies Limited (PHX.AX)
Unisys Corporation (USY.L)
Serverworks Co.,Ltd. (4434.T)
Business
Zensar Technologies Limited Zensar Technologies Limited (ZENSARTECH.NS) is a leading digital solutions and technology services company providing technology consulting, system integration, and IT services to enterprises worldwide. Headquartered in Pune, India, and founded in 2000 as a successor to operations tracing back to 1922, the company operates as a subsidiary of RPG Group and maintains a global footprint across more than 30 locations in North America, the United Kingdom, Europe, South Africa, and India, serving over 145 clients with a workforce exceeding 10,000 professionals. Zensar focuses on key industry verticals including banking, financial services and insurance (BFSI); hi-tech and manufacturing (HTM); consumer services such as retail and hospitality; and healthcare and life sciences, delivering tailored solutions through a global delivery model. The company's core products and services encompass application services including modernization, maintenance, and management; digital engineering and experience design; artificial intelligence and machine learning; cloud, infrastructure, and security management; data engineering and analytics; marketing and engagement platforms; enterprise integration via APIs and iPaaS; and industry-specific offerings such as Industry 4.0 solutions for manufacturing, omnichannel experiences for retail, core banking modernization for BFSI, and patient-centric solutions for healthcare. In recent developments, Zensar acquired BridgeView Life Sciences, LLC in July 2024 through its U.S. subsidiary to strengthen its healthcare and life sciences vertical, enhancing capabilities in biopharma cloud CRM, information management, analytics, program management, and partnerships with Veeva Systems, Reltio, Datavant, Snowflake, Salesforce, and IQVIA for pharmaceutical, biotechnology, and medical device clients. The company reported 4.0% year-over-year revenue growth in constant currency for Q2 FY25 ending September 2024, with sequential improvements in most portfolio areas, a record order book, EBITDA margin expansion to 15.4%, and strong collections reducing days sales outstanding to 71 days. Additional strategic moves include a global alliance with Saviynt for identity governance and privilege management, alongside wins in application modernization for sustainable technology and hospitality clients, SAP and AWS services for multinational firms, and IT operations transformation for UK banking.